Epidemiological situation of tick-borne encephalitis in the European Union and European Free Trade Association countries
The report summarises existing information on the occurrence of TBE to obtain a better understanding of the current magnitude of TBE in the European Union (EU) and European Free Trade Association (EFTA) countries. The specific objectives are to characterise the different reporting systems for TBE in EU/EFTA countries; to identify and assess the current epidemiological situation for TBE; identify key risk areas for the disease and provide ECDC with data into its study on burden of disease. The report is a first effort to collect existing data on TBE in EU/EFTA countries. The data, covering the period 2000–2010, were collected from different sources.
TBE Key risk areas: TBE average annual incidence rate per 100 000 inhabitants in the EU/EFTA at lower administrative level NUTS 2 (Italy) or NUTS 3
The key risk areas for TBE are located in central and eastern Europe and the Baltic and Nordic countries.
TBE Key risk groups: Number of TBE cases, regardless of the applied case definition, by age group and gender reported in 16 EU/EFTA countries, 2000–2010 (n= 22 378)
In Europe, TBE cases occurred more commonly among men than women and the number of reported cases increased with age.
TBE Cases by year: Number of TBE cases, regardless of the applied case definition, by year reported in 16 EU/EFTA countries, 2000–2010 (n= 29 381)
During the 2000–2010 period, the overall number of reported TBE cases (all case definitions combined) stayed relatively stable, with notable increases in 2003, 2006 and 2009–2010. The Czech Republic reported 25% of all reported cases, Lithuania 15%, Latvia and Germany 11% each and Slovenia 10%.
Seasonal influenza vaccination in Europe
Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007–2008 to 2014–2015.Read more
Gap analysis on securing diphtheria diagnostic capacity and diphtheria antitoxin availability in the EU/EEA
This gap analysis demonstrated that there are significant gaps in diphtheria diagnostic capacity within the EU/EEA, with only six Member States fulfilling the minimum criteria in terms of surveillance, specialised laboratory diagnostics and expertise.Read more